Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 44,310 | 38,374 | 29,373 | 21,220 | 18,167 |
| Cost of Goods | 17,064 | 15,505 | 13,260 | 10,907 | 10,528 |
| Gross Profit | 27,246 | 22,869 | 16,113 | 10,313 | 7,639 |
| Operating Expenses | 42,714 | 40,569 | 44,358 | 30,724 | 31,162 |
| Operating Income | -15,404 | -17,195 | -27,985 | -19,504 | -22,995 |
| Interest Expense | 1,570 | 1,443 | 1,474 | 2,508 | 7,729 |
| Other Income | 465 | -1,501 | -7,716 | 1,799 | -201 |
| Pre-tax Income | -16,509 | -20,139 | -37,175 | -20,213 | -30,925 |
| Income Tax | 45 | 29 | N/A | N/A | N/A |
| Net Income Continuous | -16,554 | -20,168 | -37,175 | -20,213 | -30,925 |
| Net Income | $-16,554 | $-20,168 | $-37,175 | $-20,213 | $-30,925 |
| EPS Basic Total Ops | -0.09 | -0.14 | -0.32 | -0.20 | -1.06 |
| EPS Basic Continuous Ops | -0.09 | -0.14 | -0.32 | -0.20 | -1.06 |
| EPS Diluted Total Ops | -0.09 | -0.14 | -0.32 | -0.20 | -1.06 |
| EPS Diluted Continuous Ops | -0.09 | -0.14 | -0.32 | -0.20 | -1.06 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.12 | -0.21 | -0.21 | -1.07 |
| EBITDA(a) | $-10,837 | $-12,830 | $-24,831 | $-17,614 | $-20,951 |